Securities Enforcement. Corporate Investigations. Financial Regulation.
Independent analysis of the laws, regulations, investigations, and enforcement actions shaping modern financial markets.
BRAEDEN ANDERSON
Braeden is one of the top securities lawyers in the country and was recognized by Best Lawyers: Ones to Watch® in America in the Financial Services Regulation Law and Securities Regulation categories. This honor is awarded to only the top 2% of attorneys in the United States and is based on a comprehensive peer-review survey.
Braeden helped lead Gesmer Updegrove to recognition in The Legal 500 United States for Corporate Investigations & White Collar Crime, Tier 3, and Finance: Fintech, Tier 4.
Braeden is active in the U.S. securities enforcement community through Securities Docket, where he has served on the 2025 and 2026 Advisory Boards and contributed video commentary through the Weekly Update.
Braeden was named the #1 United States author in FinTech in Mondaq’s Spring 2025 Thought Leadership Awards, reflecting the national reach and influence of his writing on fintech, securities regulation, and digital asset policy.
CFTC Proposes New CPO Registration Exemption for SEC-Registered Advisers
The CFTC's proposed CPO exemption is not a simple exit from regulation. It substitutes SEC oversight for part of the CFTC regime while creating a separate question about pools that fall outside both Form PF and Form CPO-PQR reporting.
The SEC Proposes a Rule-Based Exit From Investment-Contract Treatment
The SEC’s proposed Regulation Crypto Assets would create tailored token-offering exemptions and a Form TR process for ending Commission-administered investment-contract treatment. The proposed certainty is conditional, challengeable, and incomplete across the federal securities laws.
SEC Semiannual Reporting Proposal Would Give Issuers Flexibility, but Quarterly Reporting May Remain the Market Standard
The SEC’s proposal to permit semiannual reporting could significantly alter the public-company disclosure framework, but quarterly reporting may remain the market standard. Early surveys suggest many issuers would either continue filing Form 10-Q or maintain quarterly earnings releases even if formal SEC reporting becomes less frequent. This article examines the proposal, the potential compliance savings, investor-protection concerns, and why market expectations may ultimately determine reporting frequency.
Clinical-Trial Prediction Markets Have Arrived. Their Credibility Will Depend on Who Is Allowed to Trade.
Markets tied to drug trials and FDA decisions may improve price discovery. Their legitimacy will turn on controls governing confidential information, influence over outcomes, and cross-market manipulation. Article by Braeden Anderson.
Fifteen Years After Dodd-Frank, What Do the Data Tell Us About the Swaps Market?
Professor Ilya Beylin’s new empirical research examines whether Dodd-Frank improved or impeded U.S. swap markets. We assess his findings alongside leading academic studies on central clearing, swap execution facilities, liquidity, transaction costs, and derivatives risk management to evaluate what the post-crisis regulatory regime has actually meant for swap usage.